These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36842386)

  • 1. Drug development for the treatment of RyR1-related skeletal muscle diseases.
    Murayama T; Kurebayashi N; Ishida R; Kagechika H
    Curr Opin Pharmacol; 2023 Apr; 69():102356. PubMed ID: 36842386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient High-Throughput Screening by Endoplasmic Reticulum Ca
    Murayama T; Kurebayashi N; Ishigami-Yuasa M; Mori S; Suzuki Y; Akima R; Ogawa H; Suzuki J; Kanemaru K; Oyamada H; Kiuchi Y; Iino M; Kagechika H; Sakurai T
    Mol Pharmacol; 2018 Jul; 94(1):722-730. PubMed ID: 29674523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle weakness in Ryr1I4895T/WT knock-in mice as a result of reduced ryanodine receptor Ca2+ ion permeation and release from the sarcoplasmic reticulum.
    Loy RE; Orynbayev M; Xu L; Andronache Z; Apostol S; Zvaritch E; MacLennan DH; Meissner G; Melzer W; Dirksen RT
    J Gen Physiol; 2011 Jan; 137(1):43-57. PubMed ID: 21149547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac ryanodine receptor N-terminal region biosensors identify novel inhibitors via FRET-based high-throughput screening.
    Zhang J; Singh DP; Ko CY; Nikolaienko R; Wong King Yuen SM; Schwarz JA; Treinen LM; Tung CC; Rožman K; Svensson B; Aldrich CC; Zima AV; Thomas DD; Bers DM; Launikonis BS; Van Petegem F; Cornea RL
    J Biol Chem; 2022 Jan; 298(1):101412. PubMed ID: 34793835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Throughput Screens to Discover Small-Molecule Modulators of Ryanodine Receptor Calcium Release Channels.
    Rebbeck RT; Essawy MM; Nitu FR; Grant BD; Gillispie GD; Thomas DD; Bers DM; Cornea RL
    SLAS Discov; 2017 Feb; 22(2):176-186. PubMed ID: 27760856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the skeletal muscle ryanodine receptor/Ca2+-release channel RyR1 by S-palmitoylation.
    Chaube R; Hess DT; Wang YJ; Plummer B; Sun QA; Laurita K; Stamler JS
    J Biol Chem; 2014 Mar; 289(12):8612-9. PubMed ID: 24509862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping domains and mutations on the skeletal muscle ryanodine receptor channel.
    Hwang JH; Zorzato F; Clarke NF; Treves S
    Trends Mol Med; 2012 Nov; 18(11):644-57. PubMed ID: 23069638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural development of a type-1 ryanodine receptor (RyR1) Ca
    Mori S; Iinuma H; Manaka N; Ishigami-Yuasa M; Murayama T; Nishijima Y; Sakurai A; Arai R; Kurebayashi N; Sakurai T; Kagechika H
    Eur J Med Chem; 2019 Oct; 179():837-848. PubMed ID: 31299492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RyR1-related myopathy mutations in ATP and calcium binding sites impair channel regulation.
    Yuan Q; Dridi H; Clarke OB; Reiken S; Melville Z; Wronska A; Kushnir A; Zalk R; Sittenfeld L; Marks AR
    Acta Neuropathol Commun; 2021 Nov; 9(1):186. PubMed ID: 34809703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant hyperthermia-associated mutations in the S2-S3 cytoplasmic loop of type 1 ryanodine receptor calcium channel impair calcium-dependent inactivation.
    Gomez AC; Holford TW; Yamaguchi N
    Am J Physiol Cell Physiol; 2016 Nov; 311(5):C749-C757. PubMed ID: 27558158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RyR1-targeted drug discovery pipeline integrating FRET-based high-throughput screening and human myofiber dynamic Ca
    Rebbeck RT; Singh DP; Janicek KA; Bers DM; Thomas DD; Launikonis BS; Cornea RL
    Sci Rep; 2020 Feb; 10(1):1791. PubMed ID: 32019969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype-Phenotype Correlations of Malignant Hyperthermia and Central Core Disease Mutations in the Central Region of the RYR1 Channel.
    Murayama T; Kurebayashi N; Ogawa H; Yamazawa T; Oyamada H; Suzuki J; Kanemaru K; Oguchi K; Iino M; Sakurai T
    Hum Mutat; 2016 Nov; 37(11):1231-1241. PubMed ID: 27586648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ca2+ signaling in HEK-293 and skeletal muscle cells expressing recombinant ryanodine receptors harboring malignant hyperthermia and central core disease mutations.
    Brini M; Manni S; Pierobon N; Du GG; Sharma P; MacLennan DH; Carafoli E
    J Biol Chem; 2005 Apr; 280(15):15380-9. PubMed ID: 15689621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular calcium leak as a therapeutic target for RYR1-related myopathies.
    Kushnir A; Todd JJ; Witherspoon JW; Yuan Q; Reiken S; Lin H; Munce RH; Wajsberg B; Melville Z; Clarke OB; Wedderburn-Pugh K; Wronska A; Razaqyar MS; Chrismer IC; Shelton MO; Mankodi A; Grunseich C; Tarnopolsky MA; Tanji K; Hirano M; Riazi S; Kraeva N; Voermans NC; Gruber A; Allen C; Meilleur KG; Marks AR
    Acta Neuropathol; 2020 Jun; 139(6):1089-1104. PubMed ID: 32236737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assays for Modulators of Ryanodine Receptor (RyR)/Ca
    Murayama T; Kurebayashi N
    Curr Protoc Pharmacol; 2019 Dec; 87(1):e71. PubMed ID: 31834676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single channel properties of heterotetrameric mutant RyR1 ion channels linked to core myopathies.
    Xu L; Wang Y; Yamaguchi N; Pasek DA; Meissner G
    J Biol Chem; 2008 Mar; 283(10):6321-9. PubMed ID: 18171678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reconstituted depolarization-induced Ca2+ release platform for validation of skeletal muscle disease mutations and drug discovery.
    Murayama T; Kurebayashi N; Numaga-Tomita T; Kobayashi T; Okazaki S; Yamashiro K; Nakada T; Mori S; Ishida R; Kagechika H; Yamada M; Sakurai T
    J Gen Physiol; 2022 Dec; 154(12):. PubMed ID: 36318155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of drug modifiers for RYR1-related myopathy using a multi-species discovery pipeline.
    Volpatti JR; Endo Y; Knox J; Groom L; Brennan S; Noche R; Zuercher WJ; Roy P; Dirksen RT; Dowling JJ
    Elife; 2020 Mar; 9():. PubMed ID: 32223895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two ryanodine receptor isoforms in nonmammalian vertebrate skeletal muscle: possible roles in excitation-contraction coupling and other processes.
    Murayama T; Kurebayashi N
    Prog Biophys Mol Biol; 2011 May; 105(3):134-44. PubMed ID: 21029746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of muscle ryanodine receptor calcium release channels by proteins in the sarcoplasmic reticulum lumen.
    Beard NA; Wei L; Dulhunty AF
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):340-5. PubMed ID: 19278523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.